explore -WSS

explore

author：Wikipedia 2025-09-06 04:15:02 - browse：2

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Gene therapy has helped boys walk. Can scientists keep it that way?

knowledge

WSS

Ask STAT: What do you want to know about ChatGPT in medicine?

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

White House calls on federal agencies to crack down on AI abuses

WATCH: Why do fingernails fall off when they're damaged?

FDA approves Recor Medical high blood pressure device

FDA approves Recor Medical high blood pressure device

focus

explore

Sign up for Morning Rounds

explore

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

With FDA staff opposed to Sarepta therapy, top official intervened

Peter Hotez and the public health issue of online harassment

#NeedHerScience: shining a light on gender disparities in medicine

Walensky prepares to leave CDC — and Congress — behind

Medicare solvency divides Republicans at the presidential debate

At least 13 dead in Texas as scorching temps continue

Colonoscopy at 40? Study finds a possible benefit

Psychedelics group wrestles with new pharma identity

New guidelines on severe brain injury complicate already difficult decisions

hotspot

Excited delirium, Elijah McClain, and emergency physicians

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Cloning humans is technically possible. It's curious no one has tried

What would happen to your eyes if you looked at the solar eclipse?

10 million people disenrolled from Medicaid over past six months

MoonLake credibility takes another hit with mid

hotspot

knowledge

Wikipedia

focus